Strategies vary from launching new brands and products to just repositioning
General optimization: Start conservative (10 units) and titrate to the minimum effective dose that produces your desired effects
A placebo-controlled phase II clinical trial (NCT03987451) is evaluating the effect of semaglutide compared to placebo in patients with NAFLD and cirrhosis
Patients with a del15q genotype tend to have higher BMI (137, 176, 177) and HbA1c levels, despite similar values of glycemia, insulinemia, insulin resistance, body composition, metabolic profile, adipocyte size, resting energy expenditure, hyperphagia score, and levels of ghrelin compared to those with mUPD, suggesting a possible association between mUPD genotype and a more adverse metabolic profile, even when adjusted for BMI
R., Smiley, A., & Saadabadi, A
The meta-analysis identified a nonsignificant increase of 2.4 bpm (95% CI 0.24, 5.05) with GLP-1RA treatment relative to placebo